Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


Preimplantation Genetic Diagnosis: The Who, the What, the Why and the How


 

CRISPR reveals new cancer drug targets

11 May 2015

By Dr Indrayani Ghangrekar & Ayala Ochert

Appeared in BioNews 802

Molecular biologists have used gene-editing technology to identify promising targets for anti-cancer drugs. 

The researchers say the new method - which uses the CRISPR/Cas 9 gene-editing technique - could allow scientists to rapidly create a 'master catalogue' of the best drug targets for each type of cancer.  

Dr Christopher Vakoc and his team at Cold Spring Harbor Laboratory in New York adopted a fresh approach to cancer drug development by seeking out only those parts of a gene that encode a protein's 'binding pockets'. These pockets sit on the surface of a protein and, when a drug molecule is the right size and shape to fit inside a pocket, it can stop it from functioning.  

Using acute myeloid leukaemia cells, they used the CRISPR/Cas 9 gene-editing technique to cut out the precise sections of DNA that are responsible for each protein's binding pockets. In doing so, they were able to mimic the effect of a drug binding to that pocket - if cutting out that section of protein stopped the cancer cells from growing, then it might be a potential target for an anti-cancer drug. 

Dr Vakoc and his team used this approach to identify 25 protein domains that are essential for the survival of acute myeloid leukaemia cells - six that are already under investigation for drug development, plus 19 new potential targets. They published their results in Nature Biotechnology.  

'We can now take a very complicated protein and scan across it and try to visualise which surfaces matter most for that protein to work. We can draw a bulls-eye around the domains critical for a certain disease,' said Dr Vakoc.  

The researchers examined five proteins expressed in these leukaemia cells, but chose not to examine every single section of each protein. 'For entirely pragmatic reasons, our lab is prioritising our search to the kinds of targets [that] chemists like and are willing to design drugs against,' explained Dr Vakoc. 'We want to have an impact on cancers in the near term.' 

The researchers suggest that this approach could be used to rapidly identify all the key drug targets for each type of cancer cell. 'We now feel like we have the technology to see every weakness that a cancer cell possesses along its cell proteins. It collapses the druggable genome,' Dr Vakoc told GenomeWeb.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

30 May 2017 - by Annabel Slater 
US scientists have delayed cancer cell growth by using genome editing to remove a protein...
13 June 2016 - by Amina Yonis 
A study on the blood cancer acute myeloid leukaemia has shown which combinations of mutations lead to the most aggressive forms of the disease and revealed a complicated picture at the genetic level...
09 November 2015 - by Lone Hørlyck 
An experimental cell-based treatment using gene editing, previously only tested on mice, has successfully reversed advanced leukaemia in a one-year-old girl...
26 October 2015 - by Paul Waldron 
Scientists have used 'genome surgery' to change the way DNA is packed inside human cells...
03 August 2015 - by Lubna Ahmed 
Researchers have successfully used the technique CRISPR/Cas 9 to cut and paste genes into T-cells of the immune system...

05 May 2015 - by Dr James Heather 
US researchers have used the CRISPR/Cas9 system to target hepatitis C infection in human cells...
27 April 2015 - by Ayala Ochert 
Chinese scientists report the first-ever genetic modification of human embryos using the CRISPR/Cas9 gene-editing technique, confirming rumours that these highly controversial experiments were underway...
23 March 2015 - by Meghna Kataria 
Scientists have called for a worldwide moratorium on the use of the gene-editing technique CRISPR/Cas9 in human embryos and germ cells...
28 July 2014 - by Dr James Heather 
Research has shown that it may be possible to 'cut' the viral DNA out of cells infected by HIV using genetic editing techniques, removing its ability to replicate...
11 November 2013 - by Dr Anna Cauldwell 
A molecular technique that enables any part of the human genome to be altered with extreme precision has been hailed by scientists as a breakthrough in genetics...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Richard Anderson

Dr Sue Avery

Dr Elizabeth Garner

Professor Allan Pacey

Dr Anna Smajdor

Dr Andy Greenfield

Philippa Taylor

Dr César Palacios-González

Fiona Fox

Sarah Norcross

EARLY BIRD DISCOUNT
if you book now


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation